Mushroom acidic glycosphingolipid induction of cytokine secretion from murine T cells and proliferation of NK1.1 α/β TCR-double positive cells in vitro

Biochemical and Biophysical Research Communications

Volumn 373, Issue 3, 2008, Pages 435-439

  Nozaki, Hirofumi ^a   Itonori, Saki ^b   Sugita, Mutsumi ^b   Nakamura, Kimihide ^a   Ohba, Kiyoshi ^c   Suzuki, Akemi ^d   Kushi, Yasunori ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^b SHIGA UNIVERSITY   (Japan)

^c Hokkaido Tokachi Area Regional Food Processing Technology Center   (Japan)

^d TOKAI UNIVERSITY   (Japan)

Author keywords

Alpha galactosylceramide; Glycosphingolipids; Mouse; Mushroom; Natural killer T cells; Splenocytes; Th1 Th2 cells; Thymocytes

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CERAMIDE DERIVATIVE; CYTOKINE; GAMMA INTERFERON; GLYCOPROTEIN P 15095; GLYCOSPHINGOLIPID; INTERLEUKIN 4; ISOGLOBOTRIAOSYLCERAMIDE;

ANIMAL CELL; ARTICLE; CYTOKINE RELEASE; HYPSIZIGUS MARMOREUS; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; MUSHROOM; NONHUMAN; PLEUROTUS ERYNGII; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; TH2 CELL; THYMOCYTE;

ACIDIC GLYCOSPHINGOLIPIDS; AGARICALES; ANIMALS; ANTIGENS, SURFACE; CELL PROLIFERATION; CYTOKINES; IMMUNOLOGIC FACTORS; INTERFERON TYPE II; INTERLEUKIN-4; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MICE; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

BASIDIOMYCOTA; MURINAE; PLEUROTUS ERYNGII;

EID: 47249107691     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.06.047     Document Type: Article

References (32)

1. Godfrey D.I., and Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114 (2004) 1379-1388
2. Savage P.B., Teyton L., and Bendelac A. Glycolipids for natural killer T cells. Chem. Soc. Rev. 35 (2006) 771-779
3. Lantz O., and Bendelac A. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8-T cells in mice and humans. J. Exp. Med. 180 (1994) 1097-1106
4. Makino Y., Kanno R., Ito T., Higashino K., and Taniguchi M. Predominant expression of invariant V alpha 14+ TCR alpha chain in NK1.1+ T cell populations. Int. Immunol. 7 (1995) 1157-1161
5. Cui J., Shin T., Kawano T., Sato H., Kondo E., Toura I., Kaneko Y., Koseki H., Kanno M., and Taniguchi M. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278 (1997) 1623-1626
6. Oki S., Chiba A., Yamamura T., and Miyake S. The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. J. Clin. Invest. 113 (2004) 1631-1640
7. Brossay L., Chioda M., Burdin N., Koezuka Y., Casorati G., Dellabona P., and Kronenberg M. CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188 (1998) 1521-1528
8. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., Koseki H., and Taniguchi M. CD1d-restricted and TCR-mediated activation of Valpha14 NKT cells by glycosylceramides. Science 278 (1997) 1626-1629
9. Spada F.M., Koezuka Y., and Porcelli S.A. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 188 (1998) 1529-1534
10. Carnaud C., Lee D., Donnars O., Park S.H., Beavis A., Koezuka Y., and Bendelac A. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163 (1999) 4647-4650
11. Fujii S., Shimizu K., Smith C., Bonifaz L., and Steinman R.M. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198 (2003) 267-279
12. Uezu K., Kawakami K., Miyagi K., Kinjo Y., Kinjo T., Ishikawa H., and Saito A. Accumulation of gammadelta T cells in the lung and their regulatory roles in Th1 response and host defence against pulmonary infection with Cryptococcus neoformans. J. Immunol. 172 (2004) 7629-7634
13. La Cava A., Van Kaer L., and Fu-Dong-Shi. CD4+CD25+ trends and NKT cells: regulators regulating regulators. Trends Immunol. 27 (2006) 322-327
14. Jennemann R., Bauer B.L., Bertalanffy H., Geyer R., Gschwind R.M., Selmer T., and Wiegandt H. Novel glycoinositolphosphosphingolipids, basidiolipids, from Agaricus. Eur. J. Biochem. 259 (1999) 331-338
15. Jennemann R., Geyer R., Sandhoff R., Gschwind R.M., Levery S.B., Gröne H.J., and Wiegandt H. Glycoinositolphosphosphingolipids (basidiolipids) of higher mushrooms. Eur. J. Biochem. 268 (2001) 1190-1205
16. Dickson R.C. Sphingolipid functions in Saccharomyces cerevisiae: comparison to mammals. Annu. Rev. Biochem. 67 (1998) 27-48
17. Dickson R.C., and Lester R.L. Sphingolipid functions in Saccharomyces cerevisiae. Biochim. Biophys. Acta 1583 (2002) 13-25
18. Aoki K., Uchiyama R., Yamauchi S., Katayama T., Itonori S., Sugita M., Hada N., Yamada-Hada J., Takeda T., Kumagai H., and Yamamoto K. Newly discovered neutral glycosphingolipids in aureobasidin A-resistant zygomycetes: identification of a novel family of Gala-series glycolipids with core Gal alpha 1-6Gal beta 1-6Gal beta sequences. J. Biol. Chem. 279 (2004) 32028-32034
19. Itonori S., Yamawaki S., Aoki K., Yamamoto K., Hada N., Takeda T., Dulaney J.T., and Sugita M. Structural characterization of glycosylinositolphospholipids with a blood group type B sugar unit from the edible mushroom, Hypsizigus marmoreus. Glycobiology 18 (2008) 540-548
20. Aoki K., Uchiyama R., Itonori S., Sugita M., Che F.S., Isogai A., Hada N., Hada J., Takeda T., Kumagai H., and Yamamoto K. Structural elucidation of novel phosphocholine-containing glycosylinositol-phosphoceramides in filamentous fungi and their induction of cell death of cultured rice cells. Biochem. J. 378 (2004) 461-472
21. Zhou D., Mattner J., Cantu III C., Schrantz N., Yin N., Gao Y., Sagiv Y., Hudspeth K., Wu Y.P., Yamashita T., Teneberg S., Wang D., Proia R.L., Levery S.B., Savage P.B., Teyton L., and Bendelac A. Lysosomal glycosphingolipid recognition by NKT cells. Science 306 (2004) 1786-1789
22. Speak A.O., Salio M., Neville D.C., Fontaine J., Priestman D.A., Platt N., Heare T., Butters T.D., Dwek R.A., Trottein F., Exley M.A., Cerundolo V., and Platt F.M. Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc. Natl. Acad. Sci. USA 104 (2007) 5971-5976
23. Porubsky S., Speak A.O., Luckow B., Cerundolo V., Platt F.M., and Gröne H.J. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc. Natl. Acad. Sci. USA 104 (2007) 5977-5982
24. Galili U. The alpha-gal epitope (Gal alpha 1-3Gal beta 1-4GlcNAc-R) in xenotransplantation. Biochimie 83 (2001) 557-563
25. Okamoto N., Kanie O., Huang Y.Y., Fujii R., Watanabe H., and Shimamura M. Synthetic alpha-mannosyl ceramide as a potent stimulation for an NKT cell repertoire bearing the invariant Valpha19-Jalpha26 TCR alpha chain. Chem. Biol. 12 (2005) 677-683
26. Shimamura M., Huang Y.Y., Okamoto N., Watanabe Y., Murakami Y., Kinoshita T., Hirabayashi Y., Murakata C., Ito Y., and Ogawa T. Glycolipids with nonreducing end α-mannosyl residues that have the potential to activate invariant Vα19 NKT cells. FEBS J. 274 (2007) 2921-2932
27. Treiner E., Duban L., Bahram S., Radosavljevic M., Wanner V., Tilloy F., Affaticati P., Gilfillan S., and Lantz O. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 422 (2003) 164-169
28. Jahng A., Maricic I., Aguilera C., Carell S., Halder R.C., and Kumar V. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J. Exp. Med. 199 (2004) 947-957
29. Prigozy T.I., Naidenko O., Qasba P., Elewaut D., Brossay L., Khurana A., Natori T., Koezuka Y., Kulkarni A., and Kronenberg M. Glycolipid antigen processing for presentation by CD1d molecules. Science 291 (2001) 664-667
30. Zhou X.T., Forestier C., Goff R.D., Li C., Teyton L., Bendelac A., and Savage P.B. Synthesis and NKT cell stimulating properties of fluorophore- and biotin-appended 6″-amino-6″-deoxy-galactosylceramides. Org. Lett. 4 (2002) 1267-1270
31. Onoe K., Yanagawa Y., Minami K., Iijima N., and Iwabuchi K. Th1 or Th2 balance regulated by interaction between dendritic cells and NKT cells. Immunol. Res. 38 (2007) 319-332
32. Berner V., Liu H., Zhou Q., Alderson K.L., Sun K., Weiss J.M., Back T.C., Longo D.L., Blazar B.R., Wiltrout R.H., Welniak L.A., Redelman D., and Murphy W.J. IFN-gamma mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy. Nat. Med. 13 (2007) 354-360